Login

Early-stage fund that wants to be with its founders throughout their journey|Yves Sisteron,Managing Partner,Upfront Ventures 00:10:00

Share On Facebook Share On Twitter

Managing Partner and Co-Founder at Upfront Ventures.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Executive interview – CentralNic Group | Ben Crawford, CEO, CentralNic Group PlcCNIC:LSE
00:10:00
Fireside Chat with ACCO Brands CEO Boris Elisman: Global Strategies and Market Insights | Boris Elisman, CEO , ACCO Brand.
00:10:00
Government of Canada Supports Sunny Corner Enterprises Expansion with $500K Investment
00:10:00
PT Krida Jaringan Nusantara Tbk: Successful IPO and Future Plans | Dewi Prasetyaningsih, President , PT Krida Jaringan Nusantara Tbk.
00:10:00
Investing in Emerging Managers and Markets Its A Fireside|Paul Bragiel,Founding Partner,Golden Gate
00:10:00
Andrew Wilkinson, co-founder of Tiny Capital and WeCommerce, discussed WeCommerce's recent trading debut on CNBC with Scott Wapner.
00:00:00
Volpara Health Technologies with Proactive at the ASX Small and Mid-Cap Conference - Teri Thomas , CEO, Volpara Health Technologies Ltd
00:10:00
Focus on B2B Saas and Fintech across Europe|Julia Andre,Partner,Index Ventures
00:10:00
Erez Raphael Envisions Future of Digital Therapeutics Post Livongo Acquisition | Erez Raphael , Chief Executive Officer of Dariohealth Corp.
00:10:00
Journey of Passion: From Market Skeptic to Financial Leader | Roberto Sallouti, CEO , BTG Pactual Group.
00:10:00
Johannes Frank on Crypto Trading Strategy for Stellar 2020-2021 Performance
00:10:00
investing in mobile marketplaces social infrastructure|Sarah Tavel,General Partner,Benchmark

© 2017 - Neuhu+